A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase 1
- Study design
- RANDOMIZED · PARALLEL · OTHER · DOUBLE
- Evidence population
- Human clinical study registration
- Participants
- 50
- Population
- ALL · 60 Years to 80 Years
- Duration
- 2026-12-01 to 2028-12-01
- Intervention
- Psilocybin (Usona Institute)
- Comparator
- Wait-list Comparator
- Outcomes measured
- Change in Epigenetic/Biological Clock Profiling from Baseline to Week 4 and Week 16 — Change from Baseline to Week 4 an…; Change in Purpose in Life (PIL) from Baseline to Week 4 and Week 16 — Change from Baseline to Week 4 and Week 16; Change in Epigenetic/Biological Clock Profiling from Baseline to Week 52 — Change from Baseline to Week 52; Change in Telomere Length from Baseline to Week 52 — Change from Baseline to Week 52; Change in Purpose in Life (PIL) from Baseline to Week 52 — Change from Baseline to Week 52; Change in Satisfaction with Life from Baseline to Week 4 and Week 16 — Change from Baseline to Week 4 and Week 16; Change in Wellbeing from Baseline to Week 4 and Week 16 — Change from Baseline to Week 4 and Week 16; Change in Optimism from Baseline to Week 4 and Week 16 — Change from Baseline to Week 4 and Week 16; Change in Perceived Control/Mastery from Baseline to Week 4 and Week 16 — Change from Baseline to Week 4 and Week 16; Change in Loneliness from Baseline to Week 4 and Week 16 — Change from Baseline to Week 4 and Week 16
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 80% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Biological age biomarkers · 80%Title contains controlled topic terminology. Title supplies ageing or longevity context.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.